{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:29:29Z","timestamp":1787614169425,"version":"build-2736575974"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>While epidemiological studies have linked statin use to a reduced risk of advanced colorectal adenomas, its impact on colorectal cancer (CRC) risk in patients with inflammatory bowel disease (IBD) remains unclear. To our knowledge, no meta-analysis to date has specifically examined this association. Therefore, we conducted a systematic review and meta-analysis of the available observational studies to investigate the risk of CRC associated with statin use in IBD patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched three databases for articles published in English before September 2024, focusing on the protective effects of statins against CRC in IBD patients. We calculated multivariate odds ratios (ORs) and their 95% confidence intervals (CIs) to assess this association. A random-effects meta-analysis was conducted using the generic inverse variance method.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The meta-analysis included 4 studies encompassing 22,250 IBD patients, 6,712 of whom were statin users. The methodological quality of three of the studies was deemed high. We found a significantly lower risk of CRC in statin users compared to non-users, with a pooled relative risk of 1.88 (95% CI 1.54\u20132.30). Sensitivity analyses confirmed the consistency of these findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Statin use appears to be associated with a reduced risk of CRC in patients with IBD. However, given the limited number of studies available, further prospective research with large sample size is necessary to confirm the potential chemopreventive role of statins in this population.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1507739","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T04:35:53Z","timestamp":1732250153000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Statin exposure and risk of colorectal cancer in patients with inflammatory bowel disease: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"11","author":[{"given":"Ai-juan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-yin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-hui","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S2468-1253(19)30173-6","article-title":"Comorbidities in inflammatory bowel disease: a call for action","volume":"4","author":"Argollo","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/MIB.0b013e31828029c0","article-title":"Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies","volume":"19","author":"Lutgens","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1053\/gast.1996.v110.pm8566577","article-title":"Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"110","author":"Brentnall","year":"1996","journal-title":"Gastroenterology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1001\/jama.2022.12138","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US preventive services task force","volume":"328","author":"Chou","year":"2022","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00210-016-1252-4","article-title":"Pleiotropic effects of statins: new therapeutic targets in drug design","volume":"389","author":"Bedi","year":"2016","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.3390\/jcm13113096","article-title":"Role of lipid-lowering and anti-inflammatory therapies on plaque stabilization","volume":"13","author":"Bryniarski","year":"2024","journal-title":"J Clin Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/fcp.12495","article-title":"Key roles of rho GTPases, YAP, and mutant P53 in anti-neoplastic effects of statins","volume":"34","author":"Ji","year":"2020","journal-title":"Fundam Clin Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3390\/jcm8060819","article-title":"Effect of statin on Cancer incidence: an umbrella systematic review and Meta-analysis","volume":"8","author":"Jeong","year":"2019","journal-title":"J Clin Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.3748\/wjg.v20.i7.1858","article-title":"Statins and the risk of colorectal cancer: an updated systematic review and meta-analysis of 40 studies","volume":"20","author":"Lytras","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12944-023-01955-4","article-title":"The association of statin therapy and cancer: a meta-analysis","volume":"22","author":"Chen","year":"2023","journal-title":"Lipids Health Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"102182","DOI":"10.1016\/j.eclinm.2023.102182","article-title":"Statin use and risk of colorectal cancer in patients with inflammatory bowel disease","volume":"63","author":"Sun","year":"2023","journal-title":"EClinicalMedicine"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1002\/cncr.25731","article-title":"Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use","volume":"117","author":"Samadder","year":"2011","journal-title":"Cancer"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.5009\/gnl18178","article-title":"Statin exposure is not associated with reduced prevalence of colorectal neoplasia in patients with inflammatory bowel disease","volume":"13","author":"Shah","year":"2019","journal-title":"Gut Liver"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.cgh.2016.02.017","article-title":"Statin use is associated with reduced risk of colorectal Cancer in patients with inflammatory bowel diseases","volume":"14","author":"Ananthakrishnan","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref18","article-title":"Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane collaboration","author":"Higgins","year":"2014"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1136\/bmj.333.7568.597","article-title":"The case of the misleading funnel plot","volume":"333","author":"Lau","year":"2006","journal-title":"BMJ"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/CEJ.0000000000000152","article-title":"Statins in the chemoprevention of colorectal cancer in established animal models of sporadic and colitis-associated cancer","volume":"25","author":"Pikoulis","year":"2016","journal-title":"Eur J Cancer Prev"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/sj.leu.2402476","article-title":"HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis","volume":"16","author":"Wong","year":"2002","journal-title":"Leukemia"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cgh.2012.08.037","article-title":"Statins and colorectal cancer. Clinical gastroenterology and hepatology","volume":"11","author":"Lochhead","year":"2013","journal-title":"J Am Gastroenterol Ass"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/ibd.20074","article-title":"5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease","volume":"13","author":"Terdiman","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nrc1751","article-title":"Statins and cancer prevention","volume":"5","author":"Demierre","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2415487","DOI":"10.1080\/19490976.2024.2415487","article-title":"A gut feeling of statin","volume":"16","author":"She","year":"2024","journal-title":"Gut Microbes"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1016\/j.ajpath.2018.08.015","article-title":"The amount of Bifidobacterium genus in colorectal carcinoma tissue in relation to tumor characteristics and clinical outcome","volume":"188","author":"Kosumi","year":"2018","journal-title":"Am J Pathol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/1471-2407-8-310","article-title":"Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines","volume":"8","author":"Lee","year":"2008","journal-title":"BMC Cancer"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.gie.2014.12.009","article-title":"SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease","volume":"81","author":"Laine","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"102636","DOI":"10.1016\/j.pmedr.2024.102636","article-title":"Effects of sigmoidoscopy screening (including colonoscopy) on colorectal cancer: a meta-analysis based on randomized controlled trials","volume":"39","author":"Wang","year":"2024","journal-title":"Prev Med Rep"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.3390\/cancers16172967","article-title":"Hereditary colorectal Cancer syndromes and inflammatory bowel diseases: risk management and surveillance strategies","volume":"16","author":"Brandaleone","year":"2024","journal-title":"Cancers"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.cgh.2024.01.030","article-title":"The Management of Colorectal Neoplasia in patients with inflammatory bowel disease","volume":"22","author":"Axelrad","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.21037\/tgh-23-36","article-title":"From random to precise: updated colon cancer screening and surveillance for inflammatory bowel disease","volume":"9","author":"Fatakhova","year":"2024","journal-title":"Transl Gastroenterol Hepatol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10552-013-0326-6","article-title":"Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies","volume":"25","author":"Liu","year":"2014","journal-title":"Cancer Causes Control"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1507739\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T04:35:56Z","timestamp":1732250156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1507739\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":35,"alternative-id":["10.3389\/fmed.2024.1507739"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1507739","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"article-number":"1507739"}}